From: Genetic variants and risk of gastric cancer: a pathway analysis of a genome-wide association study
Index | Candidate causal pathway | Description | Nominal P | FDR |
---|---|---|---|---|
1 | Ephrin receptor binding | Interacting selectively and non-covalently with an ephrin receptor | <0.001 | 0.004 |
2 | Hsa00983 | Drug metabolism – other enzymes | <0.001 | 0.032 |
3 | Hsa00240 | Pyrimidine metabolism | 0.004 | 0.032 |
4 | Hsa00460 | Cyanoamino acid metabolism | 0.007 | 0.033 |
5 | Growth | The increase in size or mass of an entire organism, a part of an organism or a cell | 0.006 | 0.036 |
6 | Kidney development | The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure | 0.003 | 0.038 |
7 | Cellular cation homeostasis | The regulation of the levels, transport, and metabolism of cations within a cell or between a cell and its external environment | 0.009 | 0.039 |
8 | Urogenital system development | The process whose specific outcome is the progression of the urogenital system over time, from its formation to the mature structure | <0.001 | 0.040 |
9 | Lipid biosynthetic process | The chemical reactions and pathways resulting in the formation of lipids | 0.006 | 0.040 |
10 | Regulation of cell growth | Any process that modulates the frequency, rate or extent of cell growth | 0.002 | 0.042 |
11 | Hsa00500 | Starch and sucrose metabolism | 0.003 | 0.043 |
12 | Cation homeostasis | The regulation of the levels, transport, and metabolism of cations | 0.009 | 0.044 |